SERPINA12 and obesity disorder: Therefore, it may be a possible target in the pharmaco-therapeutic treatment of obesity and its complications.5,26 Handisurya et al. reported that weight loss following gastric bypass decreased BMI and vaspin hormones in morbidly obese subjects after 12 months.